Abstract:Objective:To develop and validate a model for postprandial blood glucose (PBG) estimation in Asian patients with type 2 diabetes mellitus (T2DM).Methods:The estimation model for PBG was developed and validated based on glycated hemoglobin (HbA 1c) and finger-based fasting blood glucose (FBG). The training cohort was drawn from a phase 4, multinational, randomized, controlled, 26-week trial comparing the efficacy and safety of insulin lispro low-mixture and insulin lispro mid-mixture as an insulin starter in Asian T2DM patients. The glycemic data at baseline (before insulin initiation) and 26 weeks were used for developing the estimation model for PBG. The validation cohort was drawn from a multicenter, randomized, and pragmatic trial comparing the efficacy and safety of basal insulin analog and insulin analog mid-mixture as an insulin starter in Chinese T2DM patients with inadequate glycemic control (HbA 1c ≥7.5%) following oral antihyperglycemic medication (OAM) treatment. The glycemic data at baseline and 24 weeks were used for validating the estimation model. Based on the data distribution of the training cohort, a linear regression model including two variables was used to develop the estimation model. The β regression coefficient of each selected model predictor and α intercept were estimated using the datasets which consisted of FBG, PBG, and HbA 1c. FBG and HbA 1c were selected as independent variables for the estimation for PBG. The goodness of fit was assessed using the decisive factor R 2. For model validation, the PBG value was estimated using this model and compared with the real PBG. The mean of individual differences between estimated PBG and real PBG and the 95% confidence interval (CI) were calculated to evaluate the accuracy of the estimation model. Additionally, the root mean square error (RMSE) was calculated. Results:The clinical trials for the training and validation cohorts enrolled, respectively, 403 and 814 patients with T2DM. Based on data distribution through scatter plot, a linear regression model including two variables, HbA 1c and FBG, was used for developing PBG estimation model: PBG (Unit: mmol/L) = 1.5×HbA 1c (Unit: %)+0.5×FBG (Unit: mmol/L)-4.1 (R 2=0.57). In the validation cohort, the estimated PBG was (13.8±3.7) mmol/L and the real PBG was (13.7±4.6) mmol/L with the individual differences between the estimated PBG and real PBG being (0.1±3.4) mmol/L, 95%CI being -0.1 to 0.3, and P being 0.525. The RMSE for the estimation model was 3.40 mmol/L. Conclusion:Patients with T2DM treated with OAM or insulin could estimate their PBG with HbA 1c and FBG using this estimation model with reasonable accuracy.

The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes

Relationship Between Hba1c and Continuous Glucose Monitoring in Chinese Population: A Multicenter Study

An estimation model for postprandial blood glucose levels in patients with type 2 diabetes mellitus

Development and economic assessment of machine learning models to predict glycosylated hemoglobin in type 2 diabetes

PDB106 ESTABLISHMENT OF HEMOGLOBIN A1C PREDICTION MODEL IN PATIENTS TYPE 2 DIABETES MELLITUSESTABLISHMENT OF HEMOGLOBIN A1C PREDICTION MODEL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

A Minimized Measurement Scheme for Predicting HbA1c Using Discrete Self-Monitoring Blood Glucose Data Within 4 Weeks for People with Type 2 Diabetes.

Predicting three-month fasting blood glucose and glycated hemoglobin changes in patients with type 2 diabetes mellitus based on multiple machine learning algorithms

Correlations Between A1c, Fasting Glucose, 2h Postload Glucose, and Β-Cell Function in the Chinese Population

Investigation on Translating Glycated Hemoglobin A1c into Mean Blood Glucose in Chinese Subjects

Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults

Role of hemoglobin A1c at different cut-off points for diabetes diagnosis

Correlation analysis of blood glucose levels throughout the day,HbA_1c and amplitude of glycemic excursions in type 2 diabetes.

Factors affecting mean blood glucose level of newly diagnosed type 2 diabetes pa-tients

A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management

Prediction of personalised postprandial glycaemic response in type 1 diabetes mellitus

Mathematical model for assessing glycemic control in type 2 diabetes mellitus

Development and validation of a prediction model for self‐reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study

Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population

Contributions of Fasting and Postprandial Glucose Concentrations to Haemoglobin A1c in Drug-Naïve Mal-Glucose Metabolism in Chinese Population Using Continuous Glucose Monitoring System

The Clinical Significance of HbA1c Combined with Fasting Blood Glucose for Screening Glucose Metabolism Abnormality in High Risk Subjects of Type 2 Diabetes

Development and Validation of a Nocturnal Hypoglycaemia Risk Model for Patients With Type 2 Diabetes Mellitus